Washington, D.C. 20549






Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): March 6, 2024



(Exact name of registrant as specified in its charter)







(State or other jurisdiction

of incorporation)


(Commission File



(IRS Employer

Identification No.)


500 Union StreetSuite 810, SeattleWashington 



(Address of principal executive offices)


(Zip Code)



(Registrant's telephone number, including area code) 



(Former name or former address, if changed since last report.) 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class


Trading Symbol(s)


Name of each exchange on which registered

Common Stock, par value $0.001




NYSE American LLC


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging Growth Company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 7.01 Regulation FD Disclosure.


On March 6, 2024, Know Labs, Inc. (the “Company”) issued a press release announcing interim results from its most recent clinical research study.


The information included in this Item 7.01 of this Current Report on Form 8-K, including the attached Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 9.01 Financial Statements and Exhibits.


Exhibit No.








Press release dated March 6, 2024. Filed herewith.



Cover Page Interactive Data File (embedded within the Inline XBRL document)







Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: March 6, 2024







/s/ Ronald P. Erickson



Name: Ronald P. Erickson



Title: Chief Executive Officer





Mar. 06, 2024
Cover [Abstract]  
Entity Registrant Name KNOW LABS, INC.
Entity Central Index Key 0001074828
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Mar. 06, 2024
Entity File Number 000-30262
Entity Incorporation State Country Code NV
Entity Tax Identification Number 90-0273142
Entity Address Address Line 1 500 Union Street
Entity Address Address Line 2 Suite 810
Entity Address City Or Town Seattle
Entity Address State Or Province WA
Entity Address Postal Zip Code 98101
City Area Code 206
Local Phone Number 903-1351
Security 12b Title Common Stock, par value $0.001
Trading Symbol KNW
Security Exchange Name NYSE
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false

Know Labs (AMEX:KNW)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Know Labs Charts.
Know Labs (AMEX:KNW)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Know Labs Charts.